NSE - Free Realtime Quote INR

Eris Lifesciences Limited (ERIS.NS)

1,688.60

+52.20

+(3.19%)

As of 3:24:44 PM GMT+5:30. Market Open.

Eris Lifesciences Ltd (NSE:ERIS) Q4 2025 Earnings Call Highlights: Robust Revenue Growth Amidst ...

Despite impressive revenue and EBITDA growth, Eris Lifesciences Ltd (NSE:ERIS) navigates product shortages and strategic hurdles.

GuruFocus.com 21 days ago

ERIS.NS
+3.19%
Three Indian Exchange Stocks Estimated To Be Up To 17.1% Below Intrinsic Value

Over the last 7 days, the Indian market has remained flat, yet it boasts an impressive 45% rise over the past year with earnings forecasted to grow by 17% annually. In such a promising environment, identifying undervalued stocks can offer significant opportunities for investors looking to capitalize on intrinsic value discrepancies.

Simply Wall St. 9 months ago

ERIS.BO

ERIS.NS
+3.19%

QUESS.BO

Performance Overview

Return	ERIS.NS	S&P BSE SENSEX (^BSESN)
YTD	+23.62%	+5.45%
1-Year	+67.17%	+7.73%
3-Year	+161.11%	+51.74%